Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

https://www.soho2019.com/

 

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
M

Safety and Efficacy of Acalabrutinib + Bendamustine / Rituximab in Patients with Treatment-Naive or R/R MCL

By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Michael Wang
By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Michael Wang
215 views
October 18, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

14:18
Incyte

Early Intervention in Chronic GVHD: Evaluating Efficacy and Safety O…

Feat. H. Ali

Featured Video

15:58
Amgen Hematology

Insights on Proteasome Inhibitor Combinations at First Relapse in Mu…

Feat. M. Levy
Mantle Cell Lymphoma
12:35

2019 Frontline Therapy for Mantle Cell Lymphoma: Cytarabine as a Key…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

S. Rule

34 views
15:27

Novel Salvage Therapy in Mantle Cell Lymphoma: Discussion on Agents …

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

S. Rule

326 views
15:47

Who Is a Candidate for Watch and Wait Therapy in MCL / What Are the …

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

A. Kumar

23 views
11:48

Safety and Efficacy of Acalabrutinib + Bendamustine / Rituximab in P…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

M. Wang

215 views